... Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy - European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol. 2008;261519-1525. 5 ...
... Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol 2008;26:1519–1525. 11. Sonis ST.
... Prospective oral mucositis audit : oral mucositis in patients receiving high - dose melphalan or BEAM conditioning chemotherapy - European Blood and Marrow Transplantation Mucositis Advisory Group . J Clin Oncol 2008 ; 26 ( 9 ) : 1519–1525 ...
... Prospective oral mucositis audit : Oral mucositis in patients receiving high - dose melphalan or BEAM conditioning chemotherapy - European Blood and Marrow Transplantation Mucositis Advisory Group . J Clin Oncol 2008 ; 26 ( 9 ) : 1519 ...
... Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy–European blood and marrow transplantation mucositis advisory group. J Clin Oncol 2008;26(9):1519–25. 15. Villa ...
... European Blood and Marrow Transplantation Mucositis Advisory Group . Prospective oral mucositis audit : oral mucositis in patients receiving high - dose melphalan or BEAM conditioning chemotherapy - European Blood and Marrow Transplantation ...
... oral health and mortality in cardiovascular diseases. J Clin Periodontol. 2001;28(8):762–8. 235. Peterson DE ... Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol. 2008;26(9):1519–25. 238. Elad S, Zadik Y ...
... Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy- European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol 2008;26:1519–1525. 169. Sonis ...
... Prospective oral mucositis audit : oral mucositis in patients receiving high - dose melphalan or BEAM conditioning chemotherapy - European Blood and Marrow Transplantation Mucositis Advisory Group . J Clin Oncol . 2008 ; 26 : 1519–25 ...
... Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol. 2008;26:1519-1525. 11. Sonis ST.